BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 21, 2011
 |  BioCentury  |  Politics, Policy & Law

What one hand giveth . . .

Obama proposes reneging on healthcare deal; would cut biologics exclusivity

In case there was any doubt, the White House made clear last week its deal with the Pharmaceutical Research and Manufacturers of America to support healthcare reform had a December 2010 expiration date.

PhRMA learned how perishable its deal was on Valentine's day, when President Obama's fiscal 2012 budget proposal was released. It asked Congress to abrogate a key part of the PhRMA deal - and the most important element for the Biotechnology Industry Organization - by slashing the exclusivity for pioneer biologics to seven years from the 12 years established in the Patient Protection and Affordable Care Act.

Presidential budget requests sent to Capitol Hill in February are all but forgotten by the time Congress passes a budget in the fall - if it manages to enact a budget at all - and there is little chance lawmakers will lop five years of exclusivity off biologics.

But other policies that would cut into drug industry revenues, such as...

Read the full 783 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >